Dr. Batoul Rostom , INSERM-CRM , France
š Dr. Batoul Rostom is a dedicated researcher in medicinal chemistry, currently a postdoctoral fellow at INSERM-Centre de Recherche en Myologie, Sorbonne University. She earned her Ph.D. in Medicinal Chemistry and Cancer Biology, where she focused on synthesizing novel cyclocoumarol derivatives with dual COX-2 inhibitory and anticancer properties. Dr. Rostom has a solid academic foundation in biochemistry and reproductive biology, with experience spanning bioinformatics, synthetic chemistry, and immunology. Her research addresses pressing issues in cancer therapeutics and autoimmune diseases. She has authored impactful publications, contributed to scientific conferences, and mentored students. Dr. Rostom’s work combines innovation with clinical relevance, aiming to bridge the gap between bench research and therapeutic applications.
Professional Profile:
Google ScholarĀ
OrcidĀ
ScopusĀ
Summary of Suitability for Award:
Dr. Batoul Rostom’s remarkable achievements, interdisciplinary expertise, and impactful research make her a deserving candidate for the “Best Researcher Award.” Her ability to translate complex scientific concepts into therapeutic applications reflects her commitment to advancing both knowledge and societal well-being. Dr. Batoul Rostom exemplifies the qualities of an outstanding researcher, with her innovative contributions to medicinal chemistry and cancer biology. Her groundbreaking work in synthesizing cyclocoumarol derivatives as dual COX-2 inhibitors with anticancer properties showcases her ability to address pressing global health challenges. Ā Dr. Rostom’s impressive academic journey, from her Ph.D. at HESAM University to her postdoctoral role at Sorbonne University, highlights her dedication to advancing science.
šEducation:
Dr. Batoul Rostom has a strong academic foundation in medicinal chemistry, biochemistry, and reproductive biology. She earned her Ph.D. in Medicinal Chemistry and Cancer Biology from HESAM University in France, where she focused on synthesizing novel cyclocoumarol derivatives with dual COX-2 inhibitory and anticancer properties. Her masterās degree in Reproductive Biology and Medical Aids from Lebanese UniversityĀ centered on the impact of smoking on TET gene expression in sperm cells, optimizing RNA extraction techniques. She holds a bachelorās degree in General Biochemistry from Lebanese University, with comprehensive training in molecular biology and biochemistry. Her education integrates interdisciplinary skills, blending synthetic chemistry, molecular biology, and bioinformatics.
š¢Work Experience:
Dr. Batoul Rostom’s career spans diverse research roles. As a postdoctoral researcher at INSERM-Centre de Recherche en Myologie, Sorbonne University , she develops therapeutic strategies for autoimmune myositis and cancer. During her Ph.D. research at CNAM in France, she synthesized and tested innovative cyclocoumarol derivatives targeting COX-2 and cancer pathways.Ā She led a COVID-19 PCR diagnostic team at Al Hadi Clinic, Lebanon, managing high-pressure operations during the pandemic. She has served as a private tutor , mentoring students in molecular biology and biochemistry. Her masterās internship explored smokingās effects on male fertility, showcasing her diverse expertise.
š
Awards:
Dr. Rostom’s remarkable achievements have earned her significant recognition in the field of medicinal chemistry. She was nominated for the prestigious International Chemistry Scientist Award for her groundbreaking contributions. As an active member of the SociĆ©tĆ© de Chimie ThĆ©rapeutique (SCT), her work in therapeutic compound design has been highly acknowledged. Her Ph.D. journey was supported by a competitive Scholarship Award, highlighting her academic excellence. Dr. Rostom also received the Top Oral Communication Award for her impactful presentations and the Young Research Fellow Distinction for her exceptional poster contributions at SCTās events. These accolades underscore her innovation, dedication, and influence in advancing scientific research.
š¬Research Focus:
Dr. Rostomās research spans medicinal chemistry, synthetic biology, and molecular biology. She specializes in designing novel cyclocoumarol derivatives, focusing on dual COX-2 inhibitors with anticancer properties. Her expertise extends to synthetic chemistry, developing compounds with pharmacological relevance. Molecular biology techniques, including RT-qPCR, ELISA, confocal microscopy, and cell culture, are central to her work. Her masterās research delved into reproductive biology, investigating smokingās effects on male fertility. Presently, she focuses on autoimmune diseases, designing therapies for myositis while leveraging bioinformatics for in silico compound development. Her interdisciplinary approach aims to bridge laboratory research with clinical applications.
Publication Top Notes:
-
-
“Fishing antioxidant 4-hydroxycoumarin derivatives: synthesis, characterization, and in vitro assessments”
-
“Coumarins derivatives and inflammation: Review of their effects on the inflammatory signaling pathways”